Preparation and properties of alkalized shikonin liposome
-
摘要: 目的 研究紫草素钠脂质体的制备工艺并考察其性质,旨在开发一种安全高效的紫草新型制剂。 方法 利用碱溶酸提法纯化紫草提取物,并采用乙醇注入法制备紫草素钠脂质体,测定其形貌、粒径和Zeta电位。利用高效液相建立左旋紫草素含量测定方法,并考察了脂质体包封率和体外释放性能。 结果 紫草素钠脂质体平均粒径为104.2 nm左右,且大小均一,成正态分布;Zeta电位为-14.8 mV;左旋紫草素在5~50 mg/L范围与峰面积呈良好的线性关系,相关系数为0.999 9;紫草素钠脂质体的包封率为43.67%,药物累积释放量为65.82%。 结论 成功制备了紫草素钠脂质体,具有较高的包封率和体外释放率。Abstract: Objective To study the preparation and properties of alkalized shikonin liposome. Methods Alkalized shikonin was purified from extracts of radix lithospermi with an alkali solution and acid formulation, and then the alkalized shikonin liposome was prepared by ethanol injection.The morphology, particle size and Zeta potential were determined, and the encapsulation efficiency and the in vitro release property were investigated.The content of L-shikonin was also measured by High Performance Liquid Chromatography. Results Alkalized shikonin liposome presented even sphere and normal distribution with particle size of 104.2 nm.The Zeta potential was-14.8 mV.L-shikonin was linear in the range of 5-50 mg/L with the correlation coefficient 0.999 9.The encapsulation efficiency was 43.67%.The final release rate was 65.82%. Conclusion Alkalized shikonin liposome was prepared successfully with good entrapment efficiency and in vitro release property.
-
Key words:
- liposome /
- radixlithospermi /
- L-shikonin /
- in vitro release property
-
[1] DRAGICEVIC-CURIC N,WINTER S,KRAJISNIK D,et al.Stability evaluation of temoporfin-loaded liposomal gels for topical application[J].J Liposome Res,2010,20(1):38-48. [2] SHEN C C,SYU W J,LI S Y,et al.Antimicrobial activities of naphthazarins from Arnebia euchroma[J].J Nat Prod,2002,65(12):1857-1862. [3] 帅冬华.紫草中化学成分及药理作用的研究进展[J].中外医疗,2009,28(22):103-104. [4] 艾庆波,刘玉璇,国大亮.中药紫草的研究进展[J].齐鲁药事,2010,29(10):609-611. [5] 严松柏,谈献和,胡玉涛.紫草的研究进展[J].时珍国医国药,2003,14(2):103-105. [6] 国家药典委员会.中华人民共和国药典2015版(一部)[S].北京:中国医药科技出版社,2015:1587. [7] 徐颖,王敏伟,中谷一泰.β-羟基异戊酰基紫草素对高表达酪氨酸激酶肿瘤细胞系的生长抑制作用[J].沈阳药科大学学报,2003,20(3):203-206. [8] 汤俊.《中国药典》含吡咯里西啶生物碱的中药品种与用药安全[J].药学学报,2011,46(7):762-772. [9] XIONG A,LI Y,YANG L,et al.Simultaneous determination of senecionine,adonifoline and their metabolites in rat serum by UPLC-ESIMS and its application in pharmacokinetic studies[J].J Pharm Biomed Anal,2009,50(5):1070-1074. [10] 李蔚仑,李军生,黄国霞,等.乙酞紫草素的潜在毒性机理研究及毒性评价[J].食品工业,2015,36(5):174-178. [11] LI H,CHEN Y,DENG Y,et al.Effects of surface charge of low molecular weight heparin-modified cationic liposomes on drug efficacy and toxicity[J].Drug Dev Ind Pharm,2017,43(7):1163-1172. [12] 岳永阳.脂质体在中药制剂中的研究及应用进展[J].首都食品与医药,2015,22(12):100-102. [13] 周彤.复方紫草凝胶剂的制备与研究[D].天津:天津工业大学,2017. [14] 咎坷,苏蕊,滕爱君,等.新疆紫草HPLC特征图谱和紫草类药材6种萘醌类成分含量测定[J].药物分析杂志,2016,36(9):1526-1535. 期刊类型引用(9)
1. 强卫平,官蜀钧. 浅析“保胃气”理论在防治脑出血并发症中的临床意义. 陕西中医药大学学报. 2022(02): 53-56 . 百度学术
2. 刘洪涛,冯守宁,董梁. 雷尼替丁联合奥美拉唑治疗重度颅脑损伤并发上消化道出血患者的效果观察. 华夏医学. 2022(02): 1-5 . 百度学术
3. 王琤毓,陈明红. 基于药物经济学研究的方法对质子泵抑制剂预防重型颅脑损伤患者应激性溃疡的分析. 海峡药学. 2020(09): 151-153 . 百度学术
4. 高慧,杨洁,胡云霞,陈秋华,鲁俊,王醒,陈明祺. 升降散对重型颅脑损伤患者胃肠功能障碍及预后影响的临床研究. 中国中医急症. 2019(04): 565-567+571 . 百度学术
5. 白荷荷,聂晓静,王园姬. 2014—2016年西安市中心医院质子泵抑制剂的使用情况分析. 现代药物与临床. 2018(07): 1814-1819 . 百度学术
6. 陈向荣,杜菊梅,张磊,吴宗涛,徐东泽. 三七白及散对基底节区、丘脑出血患者胃黏膜灌注及应激性溃疡发生率的影响. 中医药导报. 2018(18): 96-98 . 百度学术
7. 李鹏,刘建萍,黄雪英. 奥美拉唑不同给药方案预防重型颅脑损伤应激性溃疡的疗效评价. 江西医药. 2016(08): 792-793 . 百度学术
8. 巩莉. 质子泵抑制剂诱发感染危险性研究进展. 山西医药杂志. 2016(14): 1659-1660 . 百度学术
9. 孙会芳. 重症监护病房重型颅脑损伤患者继发肺部感染的相关因素分析. 中国药物经济学. 2016(06): 127-129 . 百度学术
其他类型引用(3)
-

计量
- 文章访问数: 3650
- HTML全文浏览量: 422
- PDF下载量: 367
- 被引次数: 12